Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an effective T-cell response against cancer cells. However, a small but significant percentage of patients do respond to immunotherapy, suggesting that some specific molecular subtypes of this tumor may have a better response to checkpoint inhibitors. Recent findings suggest that, in addition to their function as cancer genes, somatic mutations of PTEN, TP53, RB1, CDK12, and DNA repair, or specific activation of regulatory pathways, such as ETS or MYC, may also facilitate immune evasion of the host response against cancer. This review presents an update of recent discoveries about the role that the common somatic mutations can play in changing the tumor microenvironment and immune response against prostate cancer. We describe how detailed molecular genetic analyses of the tumor microenvironment of prostate cancer using mouse models and human tumors are providing new insights into the cell types and pathways mediating immune responses. These analyses are helping researchers to design drug combinations that are more likely to target the molecular and immunological pathways that underlie treatment failure.
Prostate cancer (PCa) is an immunologically cold tumor and the molecular processes that underlie this behavior are poorly understood. In this study, we investigated a primary cohort of intermediate-risk PCa (n = 51) using two NanoString profiling panels designed to study cancer progression and immune response. We identified differentially expressed genes (DEGs) and pathways associated with biochemical recurrence (BCR) and clinical risk. Confirmatory analysis was performed using the TCGA-PRAD cohort. Noteworthy DEGs included collagens such as COL1A1, COL1A2, and COL3A1. Changes in the distribution of collagens may influence the immune activity in the tumor microenvironment (TME). In addition, immune-related DEGs such as THY1, IRF5, and HLA-DRA were also identified. Enrichment analysis highlighted pathways such as those associated with angiogenesis, TGF-beta, UV response, and EMT. Among the 39 significant DEGs, 11 (28%) were identified as EMT target genes for ZEB1 using the Harmonizome database. Elevated ZEB1 expression correlated with reduced BCR risk. Immune landscape analysis revealed that ZEB1 was associated with increased immunosuppressive cell types in the TME, such as naïve B cells and M2 macrophages. Increased expression of both ZEB1 and SNAI1 was associated with elevated immune checkpoint expression. In the future, modulation of EMT could be beneficial for overcoming immunotherapy resistance in a cold tumor, such as PCa.
25 February 2026 in Applied Microbiology and Biotechnology
Microbial CO 2 capture coupled with biosurfactant production represents a promising strategy for greenhouse gas mitigation and sustainable biomanufacturing. This review examines the metabolic and engineering aspects of microbial carbon capture, focusing on both anaerobic and CO 2 -enriched systems within the Microbial-CCUS framework. The structural diversity, physicochemical properties, and industrial applications of microbial biosurfactants are discussed, along with emerging evidence of anaerobic biosurfactant synthesis linked to CO 2 metabolism. Advances in genetic and synthetic biology, pathway modularization, and systems-level modeling are reshaping the potential to coordinate CO 2 fixation with biosurfactant biosynthesis. Integrating artificial intelligence with metabolic engineering may further optimize productivity, scalability, and energy efficiency. Despite technical and economic challenges, the convergence of CO 2 utilization, biotechnology, and digital innovation offers a transformative route toward circular carbon systems and climate mitigation. Key points: • Microbial CO2capture drives biosurfactant synthesis within Microbial-CCUS systems . • Anaerobic and CO2-enriched cultures unlock new routes for sustainable biomanufacturing. • Synthetic biology links carbon-fixation modules to biosurfactant pathways . Graphical
10 April 2025 in Microbiology Resource Announcements
Mitigating climate crisis has driven biotechnology research toward capturing and utilizing CO 2 . Production of biosurfactants by microorganisms’ metabolism offers a promising solution. We present the draft genome of Vreelandella stevensii strain BS235 from a hypersaline alkaline lake (Pantanal biome, Brazil). We identified genes related to CO 2 metabolism and biosurfactant production.
A multiplex 6-gene copy number classifier was used to distinguish between low- or intermediate-risk prostate cancer patients. The study analysed a cohort of 448 patients and previously published datasets from radical prostatectomies. The classifier performs better than conventional stratification methods, is low cost, and can be performed easily in clinical laboratories.
13 November 2025 in Microbiology Resource Announcements
The climate crisis has stimulated research into alternative solutions for combating climate change and environmental pollution. Extremophilic microorganisms present a valuable opportunity to detoxify and degrade pollutants. We provide the complete genome of two Exiguobacterium alkaliphilum isolates from a hypersaline alkaline lake and emphasize their potential as bioremediation facilitators.